valproic acid and dolutegravir

valproic acid has been researched along with dolutegravir in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Alcantarini, C; Bonora, S; Calcagno, A; D'Avolio, A; De Nicolò, A; Di Perri, G; Milesi, M; Palazzo, A; Pirriatore, V; Trunfio, M	1
McLelland, CJ; Tseng, AL; Walmsley, SL; Wong, AYJ	1
Bax, H; Bollen, PDJ; Burger, DM; Colbers, A; de Mendonca Melo, M; de Vries-Sluijs, TEMS; Nouwen, J; Prins, HAB; Rijnders, BJA; Rokx, C; van Nood, E; Velthoven-Graafland, K; Verbon, A	1

Trials

1 trial(s) available for valproic acid and dolutegravir

Article	Year
The dolutegravir/valproic acid drug-drug interaction is primarily based on protein displacement. The Journal of antimicrobial chemotherapy, 2021, 04-13, Volume: 76, Issue:5 Topics: Drug Interactions; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Oxazines; Pharmaceutical Preparations; Piperazines; Pyridones; Valproic Acid	2021

Other Studies

2 other study(ies) available for valproic acid and dolutegravir

Article	Year
Lower dolutegravir plasma concentrations in HIV-positive patients receiving valproic acid. The Journal of antimicrobial chemotherapy, 2018, 03-01, Volume: 73, Issue:3 Topics: Anticonvulsants; Drug Interactions; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Integrase Inhibitors; Humans; Oxazines; Piperazines; Pyridones; Registries; Valproic Acid	2018
Drug interactions are not always predictable: the curious case of valproic acid and dolutegravir and a possible explanation. AIDS (London, England), 2019, 08-01, Volume: 33, Issue:10 Topics: Adult; Anticonvulsants; Blood Chemical Analysis; Drug Interactions; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Integrase Inhibitors; Humans; Oxazines; Piperazines; Pyridones; Seizures; Valproic Acid	2019

Article

Year

Lower dolutegravir plasma concentrations in HIV-positive patients receiving valproic acid.

The Journal of antimicrobial chemotherapy, 2018, 03-01, Volume: 73, Issue:3

Topics: Anticonvulsants; Drug Interactions; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Integrase Inhibitors; Humans; Oxazines; Piperazines; Pyridones; Registries; Valproic Acid

2018

Drug interactions are not always predictable: the curious case of valproic acid and dolutegravir and a possible explanation.

AIDS (London, England), 2019, 08-01, Volume: 33, Issue:10

Topics: Adult; Anticonvulsants; Blood Chemical Analysis; Drug Interactions; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Integrase Inhibitors; Humans; Oxazines; Piperazines; Pyridones; Seizures; Valproic Acid

2019